| IEDAX | RMEBX | IEDAX / RMEBX | |
| Total Expense Ratio | 0.86 | 1.07 | 80% |
| Annual Report Gross Expense Ratio | 1.04 | 1.07 | 97% |
| Fund Existence | 19 years | 12 years | - |
| Gain YTD | 13.685 | 10.367 | 132% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.6B | 118B | 2% |
| Annual Yield % from dividends | 0.71 | 0.99 | 72% |
| Returns for 1 year | 12.19 | 9.03 | 135% |
| Returns for 3 years | 21.97 | 38.30 | 57% |
| Returns for 5 years | 5.07 | 35.75 | 14% |
| Returns for 10 years | 28.46 | 90.55 | 31% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 54.46 | 0.59 | +1.10% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| NIHI | 52.84 | 0.33 | +0.62% |
| NEOS MSCI EAFE High Income ETF | |||
| QDEC | 35.95 | 0.08 | +0.22% |
| FT Vest Nasdaq-100 Buffer ETF – Dec | |||
| SPSB | 29.94 | N/A | N/A |
| State Street® SPDR® S/t Corp Bd ETF | |||
| LBO | 26.93 | N/A | N/A |
| WHITEWOLF Publicly Listed Priv Eq ETF | |||